Skip to content
AwardedSpainGoodsFramework agreement€4,469,114

2ª prorroga SUMINISTRO DE RANIBIZUMAB 10MG/ML SOLUCIÓN INYECTABLE CON DESTINO AL SERVICIO DE FARMACIA DEL HOSPITAL CLÍNICO SAN CARLOS DE MADRID

Published
Published 3 September 2025

Overview

2ª prorroga SUMINISTRO DE RANIBIZUMAB 10MG/ML SOLUCIÓN INYECTABLE CON DESTINO AL SERVICIO DE FARMACIA DEL HOSPITAL CLÍNICO SAN CARLOS DE MADRID

Key details

Country
Spain
Status
Awarded
Category
Goods
Estimated value
€4,469,114
Procedure
Open
Contract type
Framework agreement
Published
3 September 2025
Classification (CPV)
Pharmaceutical products

Award outcome

Awarded value
€894,283
Award date
27 December 2025
Contract period
— → 25 June 2026
Winners
  • LABORATORIO STADA, S.L.
  • NOVARTIS FARMACEÚTICA, S.A.
  • TEVA PHARMA, S.L.

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract Award Notice

    24 February 2026

  2. Contract Award Notice

    3 September 2025

Contracting authority

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: 2ª prorroga SUMINISTRO DE RANIBIZUMAB 10MG/ML SOLUCIÓN INYECTABLE CON DESTINO AL SERVICIO DE FARMACIA DEL HOSPITAL CLÍNICO SAN CARLOS DE MADRID — won by LABORATORIO STADA, S.L. +2 — Skim